Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists
Authors:
- Antonio Fernández-NebroAFAntonio Fernández-Nebro
- Eva TomeroETEva Tomero
- Vera Ortiz-SantamaríaVOVera Ortiz-Santamaría
- María Carmen CastroMCMaría Carmen Castro
- Alejandro OlivéAOAlejandro Olivé
- Manuel De HaroMHManuel De Haro
- Rosa García PortalesRPRosa García Portales
- Rosa García-VicuñaRGRosa García-Vicuña
- María Victoria González-MariMGMaría Victoria González-Mari
- Armando LaffónALArmando Laffón
- Rosario García-VicuñaRGRosario García-Vicuña
- 1 May 2005
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 118 (5) , 552-556
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Treatment of renal amyloidosis in rheumatoid arthritis requires further investigation: Comment on the case report by Elkayam et alArthritis & Rheumatism, 2003
- Long‐term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: An open, observational, extension study of a three‐month, randomized, placebo‐controlled trialArthritis & Rheumatism, 2003
- Anti-TNF treatment in secondary amyloidosisRheumatology, 2003
- Anti–tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: A followup report of tolerability and efficacyArthritis & Rheumatism, 2003
- Benefit of anti-TNFα treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritisAnnals of the Rheumatic Diseases, 2003
- Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximabArthritis & Rheumatism, 2002
- Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosisEuropean Heart Journal, 2002
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Treatment of the Nephrotic Syndrome with Etanercept in Patients with the Tumor Necrosis Factor Receptor–Associated Periodic SyndromeNew England Journal of Medicine, 2000
- Secondary Systemic AmyloidosisMedicine, 1991